878760431	878760431	CD	B-NP	O
|	|	NN	I-NP	O
KH	KH	NN	I-NP	O
|	|	NN	I-NP	O
36856788	36856788	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2344153	2344153	CD	B-NP	O
|	|	CC	I-NP	O
2/4/2004	2/4/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
angina	angina	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/15/2004	7/15/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/21/2004	7/21/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
FLAUDING	FLAUDING	NN	I-NP	O
,	,	,	O	O
LANCE	LANCE	NNP	B-NP	O
J.	J.	NNP	I-NP	O
485-62-27-7	485-62-27-7	CD	I-NP	O
Peake	Peake	NNP	I-NP	O
I	I	NNP	I-NP	O
Lu	Lu	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
5/11/04	5/11/04	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SALINAS	SALINAS	NNP	B-NP	O
,	,	,	O	O
SETH	SETH	NNP	B-NP	O
NORBERTO	NORBERTO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
can	can	MD	B-VP	O
reduce	reduce	VB	I-VP	O
to	to	TO	B-PP	O
81	81	CD	B-NP	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
cath	cath	NN	B-NP	B-protein
results	result	NNS	I-NP	I-protein
ATENOLOL	ATENOLOL	NN	I-NP	I-protein
50	50	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
July	July	NNP	I-NP	I-protein
HOLD	HOLD	NNP	I-NP	I-protein
IF	IF	NNP	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-VP	O
50	50	CD	B-NP	O
PEPCID	PEPCID	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FAMOTIDINE	FAMOTIDINE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
GLYBURIDE	GLYBURIDE	NNP	I-NP	O
7.5	7.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
July	July	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
start	start	VB	B-VP	O
8/3/04	8/3/04	CD	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
hold	hold	VB	B-VP	O
today	today	NN	B-NP	O
,	,	,	O	O
start	start	VB	B-VP	O
8/3/04	8/3/04	CD	B-NP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
July	July	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
resume	resume	VB	B-VP	O
outpt	outpt	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/20/04	6/20/04	CD	B-NP	O
by	by	IN	B-PP	O
BUCKE	BUCKE	NNP	B-NP	O
,	,	,	O	O
HARRY	HARRY	NNP	B-NP	O
NICKY	NICKY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
32677061	32677061	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
SL	SL	NN	I-NP	I-protein
Q5MIN	Q5MIN	NN	I-NP	I-protein
X	X	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
doses	dose	VBZ	B-VP	O
PRN	PRN	NNP	B-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
100	100	CD	I-NP	O
mmHg	mmHg	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
administer	administer	VB	I-VP	O
if	if	IN	B-SBAR	O
receiving	receive	VBG	B-VP	O
IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

IMDUR	IMDUR	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONIT	MONONIT	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
SR	SR	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
30	30	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
FOSAMAX	FOSAMAX	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ALENDRONATE	ALENDRONATE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
Instructions	Instruction	NNS	B-NP	O
:	:	:	O	O
Give	Give	VB	B-VP	O
tablet	tablet	NN	B-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
glass	glass	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
,	,	,	O	O
then	then	RB	O	O
wait	wait	VB	B-VP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
eats	eat	VBZ	B-VP	O
or	or	CC	I-VP	O
lies	lie	VBZ	I-VP	O
down	down	RP	B-PRT	O
-LRB-	-LRB-	NN	B-NP	B-protein
to	to	TO	B-VP	O
promote	promote	VB	I-VP	O
absorption	absorption	NN	B-NP	O
and	and	CC	O	O
avoid	avoid	VB	B-VP	O
distress	distress	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Food/Drug	Food/Drug	NNP	B-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
Take	Take	NN	I-NP	O
with	with	IN	B-PP	O
8	8	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
plain	plain	JJ	B-NP	O
water	water	NN	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
14	14	CD	B-NP	O
PLAVIX	PLAVIX	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
CALTRATE	CALTRATE	NNP	I-NP	O
+	+	JJ	I-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
CARB	CARB	NN	I-NP	O
+	+	SYM	B-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	I-NP	O
600MG	600MG	NN	I-NP	O
ELEM	ELEM	NN	I-NP	O
CA	CA	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Harvey	Harvey	NNP	I-NP	O
Bullen	Bullen	NNP	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
pm	pm	NN	I-NP	O
3/4/04	3/4/04	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
angina	angina	NN	B-NP	O
GERD	GERD	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
angina	angina	NNP	I-NP	O
,	,	,	O	O
CAD	CAD	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
asthma	asthma	NN	I-NP	O
htn	htn	NNP	I-NP	O
GERD	GERD	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CVA	CVA	NN	I-NP	O
rt	rt	NN	I-NP	O
sided	side	VBD	B-VP	O
weakness	weakness	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Left	Left	JJ	B-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
-	-	HYPH	B-NP	O
3V	3V	NN	I-NP	O
CAD	CAD	NN	I-NP	O
Lcx	Lcx	NN	I-NP	O
-	-	HYPH	B-NP	O
taxus	taxus	NN	I-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
mid	mid	JJ	B-NP	O
LCx	LCx	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
OM1	OM1	NN	I-NP	O
-	-	HYPH	B-NP	O
taxus	taxus	NN	I-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
RCA	RCA	NN	I-NP	O
-	-	HYPH	B-NP	O
proximal	proximal	JJ	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
ostial	ostial	JJ	I-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
intervention	intervention	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
cc	cc	NN	B-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75	75	CD	I-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
DMII	DMII	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
past	past	JJ	B-NP	O
2-3	2-3	CD	I-NP	O
months	month	NNS	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
burning	burn	VBG	I-VP	O
epigastric	epigastric	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
anginal	anginal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
per	per	IN	B-PP	O
pt	pt	NN	B-NP	O
.	.	.	O	O

was	be	VBD	B-VP	O
chest	chest	NN	B-NP	O
tightness	tightness	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
her	her	PRP$	B-NP	I-protein
epigastric	epigastric	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
investigated	investigate	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
cause	cause	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
PET	PET	NN	B-NP	O
CT	CT	NN	I-NP	O
2	2	CD	B-NP	O
months	month	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
that	that	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
LvEF	LvEF	NN	I-NP	B-protein
of	of	IN	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
inferiolateral	inferiolateral	JJ	B-NP	O
and	and	CC	I-NP	O
basal	basal	JJ	I-NP	O
anterolateral	anterolateral	JJ	I-NP	O
wall	wall	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
reversible	reversible	JJ	B-ADJP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LCx	LCx	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
12/10	12/10	CD	I-NP	I-protein
to	to	TO	B-VP	O
review	review	VB	I-VP	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
and	and	CC	O	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
current	current	JJ	B-NP	O
epigastric	epigastric	JJ	I-NP	O
burning	burning	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
direct	direct	JJ	I-NP	O
admit	admit	NN	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DMII	DMII	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	O
LAD/Lcx/OM	LAD/Lcx/OM	NN	I-NP	O
,	,	,	O	O
CVA	CVA	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
resolving	resolve	VBG	B-VP	O
Rt.	Rt.	NN	B-NP	O
hemiparesis	hemiparesis	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
CCY	CCY	NN	I-NP	O
,	,	,	O	O
osteoporosis	osteoporosis	NN	B-NP	O
,	,	,	O	O
hyperplastic	hyperplastic	JJ	B-NP	O
rectal	rectal	JJ	I-NP	O
polyp	polyp	NN	I-NP	O
,	,	,	O	O
ASCUS	ASCUS	IN	B-PP	O
98	98	CD	B-NP	O
allergies	allergy	NNS	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
or	or	CC	I-VP	O
drink	drink	VB	I-VP	O
Exam	Exam	NNP	B-NP	O
:	:	:	O	O
Tm	Tm	NNP	B-NP	O
AF	AF	NNP	I-NP	O
P	P	NNP	I-NP	O
46	46	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
138/70	138/70	CD	I-NP	O
sat	sit	VBD	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
physiologic	physiologic	JJ	B-NP	O
split	split	NN	I-NP	O
S2	S2	NN	I-NP	O
,	,	,	O	O
prominent	prominent	JJ	B-NP	O
S2	S2	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs/rubs/gallops	murmurs/rubs/gallop	NNS	I-NP	O
,	,	,	O	O
o/w	o/w	VB	B-VP	O
normal	normal	JJ	B-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
old	old	JJ	B-NP	O
1mm	1mm	NN	I-NP	O
st	st	NN	I-NP	O
depressions	depression	NNS	I-NP	O
v4-6	v4-6	NN	I-NP	B-protein
,	,	,	O	O
I.	I.	NNP	B-NP	O
Labs	Labs	NNP	I-NP	O
:	:	:	O	O
troponin	troponin	NN	B-NP	O
<	<	SYM	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

Impression	Impression	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75	75	CD	I-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
multivessel	multivessel	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
with	with	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	O
burning	burning	NN	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-NP	O
GERD	GERD	NN	I-NP	O
but	but	CC	O	O
given	give	VBN	B-VP	O
risk	risk	NN	B-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
and	and	CC	O	O
positive	positive	JJ	B-NP	O
PET	PET	NN	I-NP	O
CT	CT	NN	I-NP	O
deserves	deserve	VBZ	B-VP	O
diagnostic	diagnostic	JJ	B-NP	O
catherization	catherization	NN	I-NP	O
and	and	CC	I-NP	O
intervention	intervention	NN	I-NP	O
to	to	TO	B-VP	O
relieve	relieve	VB	I-VP	O
any	any	DT	B-NP	O
pain	pain	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

card	card	NN	B-NP	O
-	-	HYPH	I-NP	O
ischemia	ischemia	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
by	by	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	O
biomarkers	biomarker	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
ASA/BB/statin	ASA/BB/statin	NN	B-NP	O
/	/	SYM	B-NP	O
ACEI/plavix	ACEI/plavix	NN	I-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
performed	perform	VBD	B-VP	O
10/25	10/25	CD	B-NP	O
shows	show	NNS	I-NP	O
LCx	LCx	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
LCx	LCx	NN	I-NP	O
lesion	lesion	NN	I-NP	O
opened	open	VBD	B-VP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
TAXUS	TAXUS	NN	B-NP	O
stenting	stenting	NN	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
TAXUS	TAXUS	NN	I-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
ostial	ostial	JJ	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
OM1	OM1	NN	I-NP	B-protein
with	with	IN	B-PP	O
no	no	DT	B-NP	O
residual	residual	JJ	I-NP	O
occlusion	occlusion	NN	I-NP	O
.	.	.	O	O

RCA	RCA	NN	B-NP	O
disease	disease	NN	I-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
with	with	IN	B-PP	O
proximal	proximal	JJ	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
ostial	ostial	JJ	I-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
occlusions	occlusion	NNS	I-NP	O
that	that	WDT	B-NP	O
required	require	VBD	B-VP	O
no	no	DT	B-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
bradycardia	bradycardia	NN	B-NP	O
to	to	TO	B-PP	O
38	38	CD	B-NP	O
and	and	CC	O	O
SBP	SBP	NN	B-NP	O
86	86	CD	I-NP	O
.	.	.	O	O

IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
recovery	recovery	NN	B-NP	O
of	of	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
to	to	TO	B-PP	O
90	90	CD	B-NP	O
-	-	HYPH	O	O
150s	150s	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
HR	HR	NN	B-NP	B-cell_line
40s	40	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
event	event	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
any	any	DT	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
bleeding	bleed	VBG	I-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
and	and	CC	I-NP	O
integrilin	integrilin	NN	I-NP	B-protein
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
after	after	IN	B-PP	O
two	two	CD	B-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
bleeding	bleed	VBG	B-NP	O
or	or	CC	I-NP	O
associated	associate	VBN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
condition	condition	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

rhythm	rhythm	NN	B-NP	O
-	-	HYPH	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
40s	40s	CD	B-NP	O
-	-	HYPH	B-NP	O
50s	50s	CD	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Titration	Titration	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
beta-blockade	beta-blockade	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	NN	I-NP	O
.	.	.	O	O

may	may	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
becomes	become	VBZ	B-VP	O
symptomatic	symptomatic	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

GI	GI	NN	B-NP	O
-	-	HYPH	I-NP	O
continue	continue	JJ	I-NP	O
H2	H2	NN	I-NP	O
blocker	blocker	NN	I-NP	O
,	,	,	O	O
switch	switch	NN	B-NP	O
to	to	TO	B-PP	O
nexium	nexium	NN	B-NP	B-protein
if	if	IN	B-SBAR	I-protein
continued	continue	VBN	B-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endo	Endo	AFX	B-NP	B-protein
-	-	HYPH	I-NP	O
Hypoglycemics	Hypoglycemic	NNS	B-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
until	until	IN	B-PP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
resumed	resume	VBN	I-VP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

resume	resume	VB	B-VP	O
your	your	PRP$	B-NP	B-protein
previous	previous	JJ	I-NP	I-protein
medications	medication	NNS	I-NP	I-protein
2	2	CD	B-NP	I-protein
.	.	.	O	O

you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
had	have	VBD	I-VP	O
two	two	CD	B-NP	O
new	new	JJ	I-NP	O
stents	stent	NNS	I-NP	O
placed	place	VBN	B-VP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
the	the	DT	B-NP	O
vessels	vessel	NNS	I-NP	O
around	around	IN	B-PP	O
you	you	PRP	B-NP	O
heart	heart	VBP	B-VP	O
open	open	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

f/u	f/u	NN	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
,	,	,	O	O
adjust	adjust	VBP	B-VP	O
BB	BB	NNP	B-NP	O
if	if	IN	B-SBAR	O
pt	pt	NN	B-NP	O
.	.	.	O	O

symptomatic	symptomatic	JJ	B-ADJP	O
from	from	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MEINERDING	MEINERDING	NNP	B-NP	O
,	,	,	O	O
SERGIO	SERGIO	NNP	B-NP	O
ELDRIDGE	ELDRIDGE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ZX77	ZX77	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/11/04	5/11/04	CD	I-NP	O
@	@	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
47	47	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

